IL1B and COVID-19: Severe COVID-19 patients developed much higher serum concentrations of pro-inflammatory cytokines and chemokines (e.g., IL-1β, IFN-α, IL-1RA, and IL-8) than those with milder disease, indicating that the cytokine dysregulation was closely correlated with disease severity19–21.